Literature DB >> 25755824

Angel of human health: current research updates in toad medicine.

Qian Yang1, Xuanxuan Zhou1, Meng Zhang1, Linlin Bi1, Shan Miao1, Wei Cao1, Yanhua Xie1, Jiyuan Sun1, Haifeng Tang1, Ying Li1, Qing Miao1, Siwang Wang1.   

Abstract

There are currently 34 genera and 410 species of toads in the world. The medicinal parts of toads mainly include their venom, skin, and clothing. The toad's venom and skin possess the same chemical components, mainly the toad venom lactone class, and their pharmacological effects primarily include the maintenance of strong heart, antitumor, antivirus, anti-infection, and analgesic effects. So far, the produces from the medicinal raw materials of the toad are widely used clinically around the world, especially in China, Japan, and South Korea. About 50 varieties of medicines are used in the clinical treatment of various complicated diseases in China, such as "Liushen pills" which was popular in the whole world. Toads are mainly used in treating malignant tumors (e.g., liver cancer, gastric cancer, esophageal cancer, colon cancer, cervical cancer, among others), and some major diseases such as hepatitis B. Despite the therapeutic effects of toad-derived medicines on human health, there is insufficient research and development of toad-derived medicines by leading drug companies. In order to harness the beneficial effects of the resources of the toad species, it is the responsibility of global pharmaceutical researchers to develop and generate economically feasible toad-derived therapeutic products, while promoting maximum protection to the resources of the toad species.

Entities:  

Keywords:  Toad; cancer; hepatitis B

Year:  2015        PMID: 25755824      PMCID: PMC4346519     

Source DB:  PubMed          Journal:  Am J Transl Res            Impact factor:   4.060


  39 in total

1.  QSAR evaluation of the Ch'an Su and related bufadienolides against the colchicine-resistant primary liver carcinoma cell line PLC/PRF/5(1).

Authors:  Yoshiaki Kamano; Ayano Yamashita; Toshihiko Nogawa; Hiroshi Morita; Koichi Takeya; Hideji Itokawa; Toshiaki Segawa; Ayako Yukita; Kyoko Saito; Mariko Katsuyama; George R Pettit
Journal:  J Med Chem       Date:  2002-12-05       Impact factor: 7.446

Review 2.  Antitumor activity of extracts and compounds from the skin of the toad Bufo bufo gargarizans Cantor.

Authors:  Fanghua Qi; Anyuan Li; Yoshinori Inagaki; Norihiro Kokudo; Sumihito Tamura; Munehiro Nakata; Wei Tang
Journal:  Int Immunopharmacol       Date:  2010-12-24       Impact factor: 4.932

3.  Inhibitory effects of bufadienolides on interleukin-6 in MH-60 cells.

Authors:  Akiko Enomoto; Mun-Chual Rho; Kanki Komiyama; Masahiko Hayashi
Journal:  J Nat Prod       Date:  2004-12       Impact factor: 4.050

4.  Membrane dielectric responses of bufalin-induced apoptosis in HL-60 cells detected by an electrorotation chip.

Authors:  Chengjun Huang; Ailiang Chen; Min Guo; Jun Yu
Journal:  Biotechnol Lett       Date:  2007-06-26       Impact factor: 2.461

5.  Effects of bufalin on the proliferation of human choriocarcinoma cells.

Authors:  Noriyuki Takai; Tami Ueda; Terukazu Ishii; Naoko Kira; Masakazu Nishida; Yoshihiro Nishida; Kaei Nasu; Hisashi Narahara
Journal:  Int J Gynecol Cancer       Date:  2011-08       Impact factor: 3.437

6.  C23 steroids from the venom of Bufo bufo gargarizans.

Authors:  Hai-Yan Tian; Shi-Lin Luo; Jun-Shan Liu; Lei Wang; Ying Wang; Dong-Mei Zhang; Xiao-Qi Zhang; Ren-Wang Jiang; Wen-Cai Ye
Journal:  J Nat Prod       Date:  2013-09-19       Impact factor: 4.050

7.  Studies on the surface anesthetic activity of bufadienolides isolated from ch' an su.

Authors:  S Yoshida; Y Kamano; T Sakai
Journal:  Chem Pharm Bull (Tokyo)       Date:  1976-08       Impact factor: 1.645

8.  Involvement of caspases and apoptosis-inducing factor in bufotalin-induced apoptosis of Hep 3B cells.

Authors:  Chun-Li Su; Ting-Yu Lin; Chun-Nan Lin; Shen-Jeu Won
Journal:  J Agric Food Chem       Date:  2009-01-14       Impact factor: 5.279

9.  [Effect of Bufalin on proliferation and apoptosis of human non-small cell lung cancer A549 cell].

Authors:  Zhitu Zhu; Yunlong Yu; Kai Wang; Enze Li; Yangyang Liu; Yunpeng Liu
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2010-09

10.  Anticancer effects of bufalin on human hepatocellular carcinoma HepG2 cells: roles of apoptosis and autophagy.

Authors:  Qing Miao; Lin-Lin Bi; Xin Li; Shan Miao; Jin Zhang; Song Zhang; Qian Yang; Yan-Hua Xie; Jian Zhang; Si-Wang Wang
Journal:  Int J Mol Sci       Date:  2013-01-11       Impact factor: 5.923

View more
  5 in total

Review 1.  DNA Barcoding for the Identification and Authentication of Animal Species in Traditional Medicine.

Authors:  Fan Yang; Fei Ding; Hong Chen; Mingqi He; Shixin Zhu; Xin Ma; Li Jiang; Haifeng Li
Journal:  Evid Based Complement Alternat Med       Date:  2018-04-22       Impact factor: 2.629

Review 2.  The Development of Toad Toxins as Potential Therapeutic Agents.

Authors:  Ji Qi; Abu Hasanat Md Zulfiker; Chun Li; David Good; Ming Q Wei
Journal:  Toxins (Basel)       Date:  2018-08-20       Impact factor: 4.546

Review 3.  Chemistry and the Potential Antiviral, Anticancer, and Anti-Inflammatory Activities of Cardiotonic Steroids Derived from Toads.

Authors:  Hesham R El-Seedi; Nermeen Yosri; Bishoy El-Aarag; Shaymaa H Mahmoud; Ahmed Zayed; Ming Du; Aamer Saeed; Syed G Musharraf; Islam M El-Garawani; Mohamed R Habib; Haroon Elrasheid Tahir; Momtaz M Hegab; Xiaobo Zou; Zhiming Guo; Thomas Efferth; Shaden A M Khalifa
Journal:  Molecules       Date:  2022-10-05       Impact factor: 4.927

4.  Systemic delivery of the anticancer agent arenobufagin using polymeric nanomicelles.

Authors:  Xue Yuan; Qian Xie; Keyu Su; Zhijie Li; Dong Dong; Baojian Wu
Journal:  Int J Nanomedicine       Date:  2017-07-12

5.  The spinal microglial IL-10/β-endorphin pathway accounts for cinobufagin-induced mechanical antiallodynia in bone cancer pain following activation of α7-nicotinic acetylcholine receptors.

Authors:  Evhy Apryani; Usman Ali; Zi-Ying Wang; Hai-Yun Wu; Xiao-Fang Mao; Khalil Ali Ahmad; Xin-Yan Li; Yong-Xiang Wang
Journal:  J Neuroinflammation       Date:  2020-02-29       Impact factor: 8.322

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.